Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6407 ARTÍCULOS , VIENDO DEL 3166 AL 3180

Therapeutic Strategy of Targeting Astrocytes for Neuroprotection in Parkinson's Disease

Miyazaki I, Asanuma M.

Curr Pharm Des. 2017;23(33):4936-4947. doi: 10.2174/1381612823666170710163731.

Nonmotor fluctuations: phenotypes, pathophysiology, management, and open issues

Classen J, Koschel J, Oehlwein C, Seppi K, Urban P, Winkler C, Wüllner U, Storch A.

J Neural Transm (Vienna). 2017 Aug;124(8):1029-1036. doi: 10.1007/s00702-017-1757-0. Epub 2017 Jul 12.

Parkinson's disease and Parkinson's disease psychosis: a perspective on the challenges, treatments, and economic burden

Fredericks D, Norton JC, Atchison C, Schoenhaus R, Pill MW.

Am J Manag Care. 2017 Apr;23(5 Suppl):S83-S92.

Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models

Lopes FM, Bristot IJ, da Motta LL, Parsons RB, Klamt F.

Neuromolecular Med. 2017 Sep;19(2-3):241-255. doi: 10.1007/s12017-017-8454-x. Epub 2017 Jul 18.

Quantification of Hand Motor Symptoms in Parkinson's Disease: A Proof-of-Principle Study Using Inertial and Force Sensors

van den Noort JC, Verhagen R, van Dijk KJ, Veltink PH, Vos MCPM, de Bie RMA, Bour LJ, Heida CT.

Ann Biomed Eng. 2017 Oct;45(10):2423-2436. doi: 10.1007/s10439-017-1881-x. Epub 2017 Jul 19.

Chronic asymmetric tremor and levodopa-responsive parkinsonism due to a vein of Galen aneurysmal malformation

de Souza A, Fernandes YS, Bhatkar SR, Bhonsle SK.

Parkinsonism Relat Disord. 2017 Oct;43:122-123. doi: 10.1016/j.parkreldis.2017.07.007. Epub 2017 Jul 12.

Choreiform dyskinesias following levodopa treatment of parkinsonism due to osmotic demyelination syndrome

de Souza A, de Souza RJ.

Parkinsonism Relat Disord. 2017 Oct;43:120-121. doi: 10.1016/j.parkreldis.2017.07.008. Epub 2017 Jul 12.

The overlap between Essential tremor and Parkinson disease

Algarni M, Fasano A.

Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S101-S104. doi: 10.1016/j.parkreldis.2017.07.006. Epub 2017 Jul 12.

Deep Brain Stimulation in Parkinson's Disease: New and Emerging Targets for Refractory Motor and Nonmotor Symptoms

Anderson D, Beecher G, Ba F.

Parkinsons Dis. 2017;2017:5124328. doi: 10.1155/2017/5124328. Epub 2017 Jul 6.

Effectiveness of spinal cord stimulation for painful camptocormia with Pisa syndrome in Parkinson's disease: a case report

Akiyama H, Nukui S, Akamatu M, Hasegawa Y, Nishikido O, Inoue S.

BMC Neurol. 2017 Aug 3;17(1):148. doi: 10.1186/s12883-017-0926-y.

Premotor Diagnosis of Parkinson's Disease

Reichmann H.

Neurosci Bull. 2017 Oct;33(5):526-534. doi: 10.1007/s12264-017-0159-5. Epub 2017 Aug 3.

Neuropathology of Parkinson disease

Dickson DW.

Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1(Suppl 1):S30-S33. doi: 10.1016/j.parkreldis.2017.07.033. Epub 2017 Aug 1.

Botulinum Toxin in Parkinson Disease Tremor: A Randomized, Double-Blind, Placebo-Controlled Study With a Customized Injection Approach

Mittal SO, Machado D, Richardson D, Dubey D, Jabbari B.

Mayo Clin Proc. 2017 Sep;92(9):1359-1367. doi: 10.1016/j.mayocp.2017.06.010. Epub 2017 Aug 5.

Objective Measurement and Monitoring of Nonmotor Symptoms in Parkinson's Disease

Klingelhoefer L, Jitkritsadakul O, Bhidayasiri R.

Int Rev Neurobiol. 2017;133:347-387. doi: 10.1016/bs.irn.2017.04.004. Epub 2017 May 31.

Nonmotor Manifestations of Wilson's Disease

Biswas S, Paul N, Das SK.

Int Rev Neurobiol. 2017;134:1443-1459. doi: 10.1016/bs.irn.2017.04.010. Epub 2017 Jul 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias